Imaging enabled platforms for development of therapeutics

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7910, Issue , 2011, Pages

  Celli, Jonathan P ^a   Rizvi, Imran ^a,c   Blanden, Adam R ^a,b   Evans, Conor L ^a   Abu Yousif, Adnan O ^a   Spring, Bryan Q ^a   Muzikansky, Alona ^a   Pogue, Brian W ^c   Finkelstein, Dianne M ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BINGHAMTON UNIVERSITY   (United States)

^c DARTMOUTH COLLEGE   (United States)

Author keywords

3D tumor models; Benzoporphyrin derivative monoacid ring A (BPD MA); Carboplatin; Combination treatment; Imaging; Photodynamic therapy

Indexed keywords

BENZOPORPHYRIN-DERIVATIVE MONOACID; CARBOPLATIN; COMBINATION TREATMENT; IMAGING; TUMOR MODELS;

DISEASE CONTROL; DISEASES; FREE RADICALS; MOLECULAR OXYGEN; NANOPARTICLES; PHOTOSENSITIZERS; PLASMONS; PROBES; SCHEDULING; THREE DIMENSIONAL; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 79954500034     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.877293     Document Type: Conference Paper

References (12)

1. J. P. Celli, B. Q. Spring, I. Rizvi et al., "Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization, " Chem Rev, 110(5), 2795-838 (2010).
2. D. Hanahan, and R. A. Weinberg, "The hallmarks of cancer, " Cell, 100(1), 57-70 (2000). (Pubitemid 30046295)
3. B. A. Chabner, "Cytotoxic agents in the era of molecular targets and genomics, " Oncologist, 7 Suppl 3, 34-41 (2002).
4. W. C. Hahn, C. M. Counter, A. S. Lundberg et al., "Creation of human tumour cells with defined genetic elements, " Nature, 400(6743), 464-8 (1999). (Pubitemid 29361801)
5. J. Lehar, A. S. Krueger, W. Avery et al., "Synergistic drug combinations tend to improve therapeutically relevant selectivity, " Nat Biotechnol, 27(7), 659-66 (2009).
6. G. R. Zimmermann, J. Lehar, and C. T. Keith, "Multi-target therapeutics: when the whole is greater than the sum of the parts, " Drug Discov Today, 12(1-2), 34-42 (2007). (Pubitemid 46014485)
7. R. Agarwal, and S. B. Kaye, "Ovarian cancer: strategies for overcoming resistance to chemotherapy, " Nat Rev Cancer, 3(7), 502-16 (2003). (Pubitemid 37328838)
8. T. A. Yap, C. P. Carden, and S. B. Kaye, "Beyond chemotherapy: targeted therapies in ovarian cancer, " Nat Rev Cancer, 9(3), 167-81 (2009).
9. N. Ferrara, "Vascular endothelial growth factor as a target for anticancer therapy, " Oncologist, 9 Suppl 1, 2-10 (2004). (Pubitemid 38747842)
10. N. Ferrara, H. Gerber, and J. LeCouter, "The biology of VEGF and its receptors, " Nature Medicine, 9, 669-676 (2003). (Pubitemid 36749215)
11. J. P. Celli, I. Rizvi, C. L. Evans et al., "Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model, " Journal of Biomedical Optics, 15(5), 051603-10 (2010).
12. I. Rizvi, J. P. Celli, C. L. Evans et al., "Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer, " Cancer research, 70(22), 9319- 9328 (2010).